FI974618A7 - Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät - Google Patents

Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät Download PDF

Info

Publication number
FI974618A7
FI974618A7 FI974618A FI974618A FI974618A7 FI 974618 A7 FI974618 A7 FI 974618A7 FI 974618 A FI974618 A FI 974618A FI 974618 A FI974618 A FI 974618A FI 974618 A7 FI974618 A7 FI 974618A7
Authority
FI
Finland
Prior art keywords
bivalent
trivalent
small molecule
selectin inhibitors
molecule selectin
Prior art date
Application number
FI974618A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974618A0 (fi
FI974618L (fi
Inventor
Timothy P Kogan
Brian Dupre
Ian L Scott
Huong Bui
Kathy L Wheeler
Karin M Keller
Jamal M Kassir
Original Assignee
Texas Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Biotechnology Corp filed Critical Texas Biotechnology Corp
Publication of FI974618A0 publication Critical patent/FI974618A0/fi
Publication of FI974618L publication Critical patent/FI974618L/fi
Publication of FI974618A7 publication Critical patent/FI974618A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
FI974618A 1995-06-29 1996-06-26 Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät FI974618A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53395P 1995-06-29 1995-06-29
US278495P 1995-06-29 1995-06-29
PCT/US1996/011032 WO1997001335A1 (en) 1995-06-29 1996-06-26 Di- and trivalent small molecule selectin inhibitors

Publications (3)

Publication Number Publication Date
FI974618A0 FI974618A0 (fi) 1997-12-23
FI974618L FI974618L (fi) 1997-12-23
FI974618A7 true FI974618A7 (fi) 1997-12-23

Family

ID=26667782

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974618A FI974618A7 (fi) 1995-06-29 1996-06-26 Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät

Country Status (21)

Country Link
EP (1) EP0840606B1 (Direct)
JP (1) JP4046351B2 (Direct)
KR (1) KR100438136B1 (Direct)
CN (1) CN1149082C (Direct)
AT (1) ATE193647T1 (Direct)
AU (1) AU704596B2 (Direct)
BR (1) BR9608873A (Direct)
CA (1) CA2221991C (Direct)
CZ (1) CZ290072B6 (Direct)
DE (1) DE69608804T2 (Direct)
DK (1) DK0840606T3 (Direct)
ES (1) ES2146886T3 (Direct)
FI (1) FI974618A7 (Direct)
GR (1) GR3034289T3 (Direct)
HU (1) HU224590B1 (Direct)
NO (1) NO310623B1 (Direct)
PL (1) PL185372B1 (Direct)
PT (1) PT840606E (Direct)
RU (1) RU2165931C2 (Direct)
UA (1) UA52607C2 (Direct)
WO (1) WO1997001335A1 (Direct)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1020944C (zh) * 1990-01-30 1993-05-26 阿图尔-费希尔股份公司费希尔厂 紧固件
WO1998031697A1 (en) * 1997-01-15 1998-07-23 Sankyo Company, Limited Aryl c-glycoside compounds and sulfated esters thereof
WO1999029706A2 (en) * 1997-12-08 1999-06-17 Glycomed Incorporated DISALICYLATE ANALOG BASED SIALYL LEWISx MIMETICS
JP2003524598A (ja) * 1998-09-04 2003-08-19 アルタナ ファルマ アクチエンゲゼルシャフト 新規ピラノセン
PH12000002657B1 (en) 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
GB9924990D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Medicaments
US6555519B2 (en) 2000-03-30 2003-04-29 Bristol-Myers Squibb Company O-glucosylated benzamide SGLT2 inhibitors and method
US6683056B2 (en) 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
US6936590B2 (en) 2001-03-13 2005-08-30 Bristol Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
JP5183010B2 (ja) 2002-05-16 2013-04-17 グリコミメティクス， インコーポレイテッド セレクチンによって媒介される機能を阻害するための化合物および方法
EP1763533B1 (en) 2003-11-19 2008-01-09 GlycoMimetics, Inc. Specific antagonist for both e- and p-selectins
EP1577289A1 (en) 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1928892B1 (en) 2005-08-09 2011-10-12 GlycoMimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
CN103626813B (zh) 2005-09-02 2017-05-03 糖模拟物有限公司 异型双功能全选择素抑制剂
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764096A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
KR100827674B1 (ko) * 2006-05-23 2008-05-07 (주)한빛테크 자동트립 장치와 그 제어방법
EP1897533A1 (en) * 2006-09-08 2008-03-12 Revotar Biopharmaceuticals AG Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions
EP1903049A1 (en) * 2006-09-08 2008-03-26 Revotar Biopharmaceuticals AG Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyloxy)-phenyl] hexane
EP1958637A1 (en) * 2007-02-14 2008-08-20 Revotar Biopharmaceuticals AG Pharmaceutical composition for the treatment of IL-8 mediated diseases
WO2009086277A1 (en) 2007-12-20 2009-07-09 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CA2798383A1 (en) * 2010-05-07 2011-11-10 Revotar Biopharmaceuticals Ag Process for the preparation of bimosiamose
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
CN104039805B (zh) 2011-12-22 2016-11-16 糖模拟物有限公司 E-选择蛋白拮抗剂化合物、组合物及使用方法
EP2928476B1 (en) 2012-12-07 2018-02-14 GlycoMimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
KR102542750B1 (ko) 2014-12-03 2023-06-12 글리코미메틱스, 인크. E-셀렉틴 및 cxcr4 케모카인 수용체의 헤테로이작용성 억제제
JP2019524791A (ja) 2016-08-08 2019-09-05 グリコミメティクス， インコーポレイテッド Ｅ−セレクチンの阻害剤もしくはｃｘｃｒ４の阻害剤との、またはｅ−セレクチンおよびｃｘｃｒ４両方のヘテロ二機能性阻害剤とのｔ細胞チェックポイント阻害剤の組み合わせ
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
AU610160B2 (en) * 1987-05-06 1991-05-16 Adir Et Compagnie New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2129140A1 (en) * 1992-01-31 1993-08-05 Akira Hasegawa Lewis-type sugar chain derivative
US5444050A (en) * 1994-04-29 1995-08-22 Texas Biotechnology Corporation Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
US5498775A (en) * 1994-11-07 1996-03-12 American Home Products Corporation Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation

Also Published As

Publication number Publication date
RU2165931C2 (ru) 2001-04-27
DE69608804D1 (de) 2000-07-13
NO976074L (no) 1998-03-02
HU224590B1 (hu) 2005-11-28
CZ407597A3 (cs) 1998-07-15
EP0840606A4 (Direct) 1998-05-13
KR19990028441A (ko) 1999-04-15
NO310623B1 (no) 2001-07-30
PT840606E (pt) 2000-11-30
FI974618A0 (fi) 1997-12-23
CN1196678A (zh) 1998-10-21
KR100438136B1 (ko) 2004-08-25
DK0840606T3 (da) 2000-08-07
DE69608804T2 (de) 2000-11-02
EP0840606A1 (en) 1998-05-13
FI974618L (fi) 1997-12-23
CA2221991A1 (en) 1997-01-16
AU704596B2 (en) 1999-04-29
UA52607C2 (uk) 2003-01-15
CZ290072B6 (cs) 2002-05-15
HUP9802602A3 (en) 1999-08-30
WO1997001335A1 (en) 1997-01-16
CA2221991C (en) 2007-09-18
EP0840606B1 (en) 2000-06-07
CN1149082C (zh) 2004-05-12
BR9608873A (pt) 1999-07-06
PL324330A1 (en) 1998-05-25
NO976074D0 (no) 1997-12-23
GR3034289T3 (en) 2000-12-29
JPH11508885A (ja) 1999-08-03
ES2146886T3 (es) 2000-08-16
HUP9802602A2 (hu) 1999-02-01
AU6292396A (en) 1997-01-30
JP4046351B2 (ja) 2008-02-13
PL185372B1 (pl) 2003-04-30
ATE193647T1 (de) 2000-06-15

Similar Documents

Publication Publication Date Title
FI974618A7 (fi) Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät
FI963597A7 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
DE69508485D1 (de) Absperrhahn
NO981938D0 (no) Proteaseinhibitorer
NO942064D0 (no) yminhibitorer
NO952865D0 (no) 6-leddede nitrogenholdige heteroaryl-oksazolidinoner
DE59604782D1 (de) Einspritzventil
NO974403D0 (no) Reversible proteasehemmere
DE59604308D1 (de) Einspritzventil
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DK0692174T3 (da) Koblede registre
FI961044L (fi) Kininogeeni-inhibiittorit
EP0783305A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0812203A4 (en) INHIBITORS OF GERANYLGERANYL PROTEIN TRANSFERASE
DE69623249D1 (de) Dreitoriger Schlitzleitungszirkulator
PT948483E (pt) Inibidores da farnesil-transferase
DE69626316D1 (de) Elektromagnet
LV11325A (lv) Skvalena sintetazes inhibitori
EP0787123A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
BR9604841A (pt) Válvula não mecánica
BR9610514A (pt) Inibidores cicloantihelmínticos
DE59504989D1 (de) Einspritzventil
BR9509256A (pt) Memória permamente

Legal Events

Date Code Title Description
MA Patent expired